![](/img/cover-not-exists.png)
A randomized clinical trial to identify the optimal antigen and MF59® adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects
Christoph Hatz, Frank von Sonnenburg, Daniela Casula, Maria Lattanzi, Geert Leroux-RoelsVolume:
30
Year:
2012
Language:
english
DOI:
10.1016/j.vaccine.2012.03.017
File:
PDF, 668 KB
english, 2012